Senti Biosciences SNTI

Senti Biosciences Holdings, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$1.77-36.56%close on Nov. 20, 2026 · volume 39K · Yahoo Finance

Price, last 64 sessions

$1.00$2.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 20, 2026 · high $2.79 · low $0.09 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 20 →
  • 8-KNov. 20, 2026, 4:36 p.m. ETView on SEC.gov

    Change in certifying accountant · Financial statements and exhibits

  • 8-KNov. 18, 2026, 4:15 p.m. ETView on SEC.govOur explainer

    Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits

    AI summary, unreviewedSenti Biosciences (SNTI) effects 1-for-33 reverse stock split effective November 18, 2026, trading split-adjusted from November 19

  • SCHEDULE 13D/ANov. 18, 2026, 4:49 p.m. ETView on SEC.gov
  • SCHEDULE 13D/ANov. 18, 2026, 5:54 p.m. ETView on SEC.gov
  • 10-QNov. 16, 2026, 4:11 p.m. ETView on SEC.gov
  • SCHEDULE 13G/ANov. 13, 2026, 4:53 p.m. ETView on SEC.gov
  • 8-KNov. 10, 2026, 4:36 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits

    AI summary, unreviewedSenti Biosciences Holdings Signs Up to $4.55 Million Equity Commitment With Celadon-Affiliated Investor, Priced at Nasdaq Minimum Price

  • 8-KOct. 27, 2026, 4:38 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Other events

    AI summary, unreviewedSenti Biosciences Announces Director Edward Mathers' Resignation and Sets October 30, 2026 Record Date for CVR Distribution